C12Y 207/07012
Udp-glucose--hexose-1-phosphate uridylyltransferase
Official title: UDP-glucose--hexose-1-phosphate uridylyltransferase (2.7.7.12)
C12Y207/07012 (Udp-glucose--hexose-1-phosphate uridylyltransferase) appears on 21 US grants and 57 published applications in this corpus.
Search patents in C12Y- Granted patents
- 21
- Published applications
- 57
- Assignees
- 19
- Inventors
- 64
- Latest grant
- 18 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 2 |
| 2014 | 0 | 26 |
| 2015 | 9 | 2 |
| 2016 | 2 | 1 |
| 2017 | 2 | 2 |
| 2018 | 1 | 3 |
| 2019 | 2 | 2 |
| 2020 | 2 | 2 |
| 2021 | 0 | 3 |
| 2022 | 1 | 2 |
| 2023 | 1 | 2 |
| 2024 | 1 | 3 |
| 2025 | 0 | 5 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Production of steviol glycosides through whole cell biotransformation of steviol glycoside intermediates18 Jun 2024US 12,012,626 B2Manus Bio Inc.
- Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins31 Jan 2023US 11,564,998 B2ModernaTX, Inc.
- Production of steviol glycosides through whole cell biotransformation of steviol glycoside intermediates25 Jan 2022US 11,230,724 B2Manus Bio Inc.
- Modified Polynucleotides for the production of biologics and proteins associated with human disease15 Sep 2020US 10,772,975 B2ModernaTX, Inc.
- In vivo production of proteins10 Mar 2020US 10,583,203 B2ModernaTX, Inc.
- Galactose-1-phosphate uridyltransferase mutant and use thereof in preparation of l-lysine30 Jul 2026US 2026/0218255 A1Ningxia Eppen Biotech Co., Ltd
- In vivo production of proteins25 Jun 2026US 2026/0174909 A1ModernaTX, Inc.
- Method of modulating the alkaloid content of tobacco11 Sep 2025US 2025/0283103 A1Nicoventures Trading Limited
- T-dna vector encoding a post-translational modification enzyme and lacking regulatory sequences for its expression17 Apr 2025US 2025/0122518 A1PlantForm Corporation
- T-dna vector encoding a post-translational modification enzyme and lacking regulatory sequences for its expression17 Apr 2025US 2025/0122519 A1PlantForm Corporation
Most cited
By later US patents
- Modified polynucleotides for the production of biologics and proteins associated with human disease196US 8,999,380 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides for treating protein deficiency194US 9,061,059 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1124US 9,095,552 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides encoding citeD4124US 9,114,113 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides for treating galactosylceramidase protein deficiency121US 9,089,604 B2Moderna Therapeutics, Inc. · 2015